S100A14,a member of EF-hand Calcium-Binding Proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling [Molecular Bases of Disease]

November 27th, 2013 by Xu, C., Chen, H., Wang, X., Gao, J., Che, Y., Li, Y., Ding, F., Luo, A., Zhang, S., Liu, Z.

HER2 is overexpressed in 20-25% of breast cancers. Overexpression of HER2 is an adverse prognostic factor and correlates with decreased patient survival. HER2 stimulates breast tumorigenesis via a number of intracellular signaling molecules including PI3K/AKT and MAPK/ERK. S100A14, one member of the S100 protein family, is significantly associated with outcome of breast cancer patients. Here, for the first time, we show that S100A14 and HER2 are coexpressed in invasive breast cancer specimens, and there is a significant correlation between the expression levels of the two proteins by immunohistochemistry. S100A14 and HER2 are colocalized in plasma membrane of breast cancer tissue cells and breast cancer cell lines BT474 and SK-BR3. We demonstrate that S100A14 binds directly to HER2 by co-immunoprecipitation and pull down assays. Further study shows that residues 956-1154 of HER2 intracellular domain and the residue 83 of S100A14 are essential for the two proteins binding. Moreover, we observe a decrease of HER2 phosphorylation, downstream signaling, and HER2-stimulated cell proliferation in S100A14-silenced MCF-7, BT474 and SK-BR3 cells. Our findings suggest that S100A14 functions as a modulator of HER2 signaling and provide mechanistic evidence for its role in breast cancer progression.
  • Posted in Journal of Biological Chemistry, Publications
  • Comments Off on S100A14,a member of EF-hand Calcium-Binding Proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling [Molecular Bases of Disease]